Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis.
about
The emerging role of oxylipins in thrombosis and diabetesFactors influencing the eicosanoids synthesis in vivoPlatelet 12-LOX is essential for FcγRIIa-mediated platelet activation.Transcription Factor RUNX1 Regulates Platelet PCTP (Phosphatidylcholine Transfer Protein): Implications for Cardiovascular Events.Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.12-lipoxygenase: a potential target for novel anti-platelet therapeutics.Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axis.Synthesis of indole derived protease-activated receptor 4 antagonists and characterization in human plateletsProtein kinase C regulation of 12-lipoxygenase-mediated human platelet activation.Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer.Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation.Identifying determinants of variability to tailor aspirin therapy.First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis.New Concepts and Mechanisms of Platelet Activation Signaling.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?12-hydroxyeicosatetraenoic acid is associated with variability in aspirin-induced platelet inhibition.Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma MetastasisAnalysis of HETEs in human whole blood by chiral UHPLC-ECAPCI/HRMS.12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity.The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting.
P2860
Q26823893-B0570E2A-92A8-4B41-A9A8-8B63EDC57FCCQ28083767-A9715EEA-4EE7-4000-8EA9-870797CB84EAQ33416935-7912F37B-BDC6-425C-8905-CA510CD32EBBQ33443278-608A8108-F7AB-4A60-B9A2-764BB4956440Q33955652-395C1B0D-B7B9-4C83-BEBE-058AFDB7BEF2Q34207687-F6E16807-270F-4DAA-B219-3E97F9A56131Q34550588-DC772BF9-13D7-4B56-AEC8-73F67C33F5D4Q34775758-62DC7420-C994-4F93-AE68-78B348E3DA92Q35776733-C38955D0-6CBD-495B-B1B2-21A8DC70077CQ35941710-32A8C399-C3BE-4A6E-B5D3-FADFF8B4F801Q36322931-55DE7E67-1DDE-4D22-91E2-5278F2E676F0Q36387226-A4684071-6C9A-43F9-B69F-45BA2208E754Q38087384-0A83E3C5-AFF9-4429-8382-C2DFE57A1F4BQ38642400-658007FC-5F77-43E0-8023-1A97866E3A9EQ39147112-07DC6067-3DCC-4F98-9564-6A42FCD48AE5Q41420993-197B6D5E-1A5F-493C-9F2E-DA66B4D50F68Q41917191-8C0213D8-4A3C-452A-AF38-16B2DF418FF4Q42731074-0CCE7746-A380-410B-964F-D280F3628C07Q50119814-E3EB361E-0001-4A5E-AEB0-6174DD2F16ECQ50893125-86A47F60-EDBD-4CDD-9FEA-F902B3C17B70Q55284640-1A8EA870-FC3A-4112-BC6D-FFB7CEFDA97D
P2860
Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@ast
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@en
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@nl
type
label
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@ast
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@en
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@nl
prefLabel
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@ast
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@en
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@nl
P2093
P2860
P1476
Protease-activated receptor si ...... and 12-lipoxygenase catalysis.
@en
P2093
Heidi E Hamm
Joanne Vesci
John A Oates
Manju Bala
Michael Holinstat
Olivier Boutaud
Patrick L Apopa
P2860
P304
P356
10.1161/ATVBAHA.110.219527
P407
P577
2010-12-02T00:00:00Z